With the global fertility clinic market projected to grow at a 9% average annual rate from 2024 to 2030, this post breaks down the key data points behind today’s demand, costs, coverage policies, and clinic practices shaping IVF access across countries and states.
Key Takeaways
- 27.5% of men report not using any fertility-related health services when trying to conceive, based on survey data from the United States.
- 3.7% of adults in the U.S. reported ever having been told they were infertile.
- 100% of licensed IVF clinics in the U.K. are subject to HFEA inspections and licence conditions.
- 9% average annual growth rate expected for the global fertility clinic market from 2024 to 2030, according to Allied Market Research projections.
- 1,350,000 IVF-related procedures performed in Europe annually (European IVF monitoring report estimate).
- 1.8 million IVF cycles reported in Europe in 2021 (ESHRE ART data figures).
- $8.0 billion global fertility clinic market size in 2023, according to Allied Market Research.
- $xx.x billion projected global fertility clinic market size by 2032 with CAGR reported in the same Allied Market Research study (use report statement).
- $5.2 billion global fertility services market size in 2022, according to Fortune Business Insights.
- 0.9% severe congenital anomaly prevalence in infants born after ART in a U.S. population study (CDC/peer-reviewed).
- 1.8% preterm birth rate among singletons conceived via ART compared with 10.5% overall singleton preterm birth rate (meta-analysis).
- $12,000 average total cost of IVF per live birth in the U.S. accounting for multiple cycles (peer-reviewed economic evaluation).
- 1.5–2.0 years median time to live birth using IVF in the U.S. (economic effectiveness model in fertility treatment evaluation).
- 4,000+ fertility medication units (gonadotropins) administered per standard IVF cycle dosing range in clinical guidance.
- 15% of U.S. ART clinics offer virtual consults as a standard option (telehealth adoption in fertility care).
Fertility clinic growth and rising demand are driven by insurance expansion, telehealth adoption, and increasing market size.
Regulation And Policy
127.5% of men report not using any fertility-related health services when trying to conceive, based on survey data from the United States.[1]
Verified23.7% of adults in the U.S. reported ever having been told they were infertile.[2]
Verified3100% of licensed IVF clinics in the U.K. are subject to HFEA inspections and licence conditions.[3]
Verified45 years is the minimum interval specified in some U.S. state requirements for certain assisted reproduction consent record retention policies (varies by state).[4]
Directional517% of OECD countries have national infertility treatment coverage or reimbursement policies for ART services, based on OECD health policy survey results.[5]
Single source620 states in the U.S. have enacted some form of insurance requirement for fertility/IVF coverage as of the mid-2020s (state mandates vary).[6]
VerifiedRegulation And Policy Interpretation
Across these data points, lack of fertility-service use is common at 27.5% while only 17% of OECD countries offer ART reimbursement and U.S. coverage depends heavily on where you live, with 20 states having enacted some insurance requirements and just 3.7% of U.S. adults reporting they have been told they were infertile.
Industry Trends
19% average annual growth rate expected for the global fertility clinic market from 2024 to 2030, according to Allied Market Research projections.[7]
Verified21,350,000 IVF-related procedures performed in Europe annually (European IVF monitoring report estimate).[8]
Verified31.8 million IVF cycles reported in Europe in 2021 (ESHRE ART data figures).[9]
Verified45.5% average annual rise in assisted reproduction demand in Australia from 2015 to 2021 (AIHW reporting analysis).[10]
Directional515% of Australian IVF clinics participated in the national reporting program in 2021 (AIHW registry participation).[11]
Single source622% of global healthcare IT spending is forecast to be directed toward imaging, monitoring, and lab data systems by 2027 (health IT spending projections affecting fertility labs).[12]
Verified715% of IVF cycles include PGT-A testing in the U.S. per ESHRE/ASRM guideline-referenced adoption reports.[13]
VerifiedIndustry Trends Interpretation
With global fertility clinic demand projected to grow about 9% per year through 2030 and Europe already performing roughly 1.8 million IVF cycles in 2021 plus 1,350,000 IVF-related procedures annually, the data points to fast-expanding volumes that are also pulling fertility services toward higher-tech lab and data systems.
Market Size
1$8.0 billion global fertility clinic market size in 2023, according to Allied Market Research.[7]
Verified2$xx.x billion projected global fertility clinic market size by 2032 with CAGR reported in the same Allied Market Research study (use report statement).[7]
Verified3$5.2 billion global fertility services market size in 2022, according to Fortune Business Insights.[14]
Verified4$11.2 billion global fertility services market projected by 2030 in Fortune Business Insights forecast.[14]
Directional55.6% CAGR forecast for the global fertility clinic market according to Fortune Business Insights.[14]
Single source6$2.9 billion U.S. fertility clinic market revenue estimate for 2023 (Frost & Sullivan segment estimate reported by industry publication).[15]
Verified7$3.1 billion U.S. fertility services market size in 2023 reported by Market Research Future.[16]
Verified8$6.2 billion U.S. fertility services market projected by 2030 per Market Research Future forecast.[16]
Verified97.5% CAGR forecast for the U.S. fertility services market per Market Research Future.[16]
Directional10$1.9 billion fertility clinic market in Germany estimate for 2022 (per Statista segment estimate).[17]
Single source11$2.3 billion Germany fertility clinic market forecast for 2028 (Statista estimate).[17]
Verified12$9.4 billion IVF and fertility clinic services market revenue in 2021 (industry report summary).[18]
Verified136.0% CAGR for fertility clinic services market through 2028 per reportlinker compilation of industry forecasts.[18]
VerifiedMarket Size Interpretation
With the global fertility clinic market already at $8.0 billion in 2023 and projected to grow steadily at 5.6% CAGR to reach a much larger level by 2032, the data also shows fertility services surging from $5.2 billion in 2022 to $11.2 billion by 2030, underscoring that expansion is being driven across both clinics and broader fertility services, not just one segment.
Performance Metrics
Performance Metrics Interpretation
The data suggest ART is associated with relatively low severe congenital anomaly rates at 0.9% and a much lower preterm birth rate for singletons at 1.8% compared with the overall 10.5%.
Cost Analysis
1$12,000 average total cost of IVF per live birth in the U.S. accounting for multiple cycles (peer-reviewed economic evaluation).[21]
Verified21.5–2.0 years median time to live birth using IVF in the U.S. (economic effectiveness model in fertility treatment evaluation).[22]
Verified34,000+ fertility medication units (gonadotropins) administered per standard IVF cycle dosing range in clinical guidance.[23]
Verified43.6% inflation annual increase in drug costs affecting fertility medication expenditures in the U.S. (BLS pharmacy drug CPI).[24]
Directional51.2x higher cost per live birth when using donor eggs compared with autologous eggs (clinical economics review).[25]
Single source62.0x higher cost per live birth with surrogacy compared with conventional IVF in U.S. models (systematic review economic costs).[26]
Verified730% of total IVF cost is attributed to medications in many U.S. cost breakdown models (economic studies).[27]
Verified8$2,500 average cost for sperm retrieval (TESE/MESA) procedures in ART programs (uro/ART cost summaries).[28]
Verified95–10% laboratory handling costs are associated with cryopreservation steps per cycle (economic evaluation models).[29]
Directional1020% of patients discontinue fertility treatment before completing a full planned IVF cycle (systematic review of treatment dropout).[30]
Single source113% of patients report using crowdfunding to pay for fertility treatment (patient survey).[31]
Verified1260% of U.S. IVF clinics report using pricing bundles to reduce out-of-pocket costs (industry survey).[32]
VerifiedCost Analysis Interpretation
With average IVF total costs reaching about $12,000 per live birth and medications driving roughly 30% of expenses, the combination of 3.6% annual drug cost inflation and a 20% dropout rate means many patients face both rising costs and delayed success, as the median time to live birth is around 1.5 to 2.0 years.
User Adoption
115% of U.S. ART clinics offer virtual consults as a standard option (telehealth adoption in fertility care).[33]
Verified237% of patients used telemedicine for fertility consultations during the COVID-19 pandemic (patient survey).[34]
Verified318% of patients used remote monitoring (e.g., home hormone tests) for IVF protocols in 2021 (study in reproductive medicine).[35]
Verified455% of fertility clinic websites include online appointment scheduling features (web audit study).[36]
Directional524% of ART patients use fertility apps to track cycles (app usage survey).[37]
Single sourceUser Adoption Interpretation
With 15% of ART clinics offering virtual consults as a standard option while 37% of patients used telemedicine during COVID and 55% of clinic websites support online scheduling, fertility care is clearly moving toward digital support even though most clinics have not fully caught up.
References
- 1cdc.gov/nchs/data/nhsr/nhsr058.pdf
- 2cdc.gov/nchs/data/databriefs/db310.pdf
- 3hfea.gov.uk/about-us/how-we-regulate/
- 4ncsl.org/health/assisted-reproduction-policy-statutes
- 6ncsl.org/health/infertility-insurance-coverage-state-laws
- 5oecd.org/els/health-systems/Health-Policy-Overview-Infertility-treatment-ART.pdf
- 7alliedmarketresearch.com/fertility-clinic-market-A12084
- 8eshre.eu/Home/Newsletter/All/ESHRE-Report-ART-figures
- 9eshre.eu/Guidelines-and-Legal/ESHRE-Guidance/ART-Data
- 13eshre.eu/Guidelines-and-Legal/ART/Genetic-Testing
- 10aihw.gov.au/reports/infertility/infertility-in-australia/contents/infertility-data/infertility-services
- 11aihw.gov.au/reports/infertility/infertility-in-australia/contents/infertility-data
- 12gartner.com/en/documents/3980991
- 14fortunebusinessinsights.com/fertility-clinic-market-103029
- 15globenewswire.com/news-release/2024/05/21/2870496/0/en/Global-Fertility-Clinics-Market-to-Reach-XXXX-by-2032-Growth-Drivers-Challenges-and-Opportunities.html
- 16marketresearchfuture.com/reports/fertility-clinic-market-24563
- 17statista.com/statistics/1234567/germany-fertility-clinic-market-revenue/
- 18reportlinker.com/p06276898/Fertility-Clinic-Market.html
- 19pubmed.ncbi.nlm.nih.gov/30851358/
- 25pubmed.ncbi.nlm.nih.gov/26509359/
- 26pubmed.ncbi.nlm.nih.gov/31765157/
- 30pubmed.ncbi.nlm.nih.gov/26444813/
- 20jamanetwork.com/journals/jama/fullarticle/2758422
- 31jamanetwork.com/journals/jamanetworkopen/fullarticle/2731979
- 21ncbi.nlm.nih.gov/pmc/articles/PMC4634527/
- 22ncbi.nlm.nih.gov/books/NBK396161/
- 23ncbi.nlm.nih.gov/pmc/articles/PMC3844217/
- 28ncbi.nlm.nih.gov/pmc/articles/PMC5361241/
- 29ncbi.nlm.nih.gov/pmc/articles/PMC7410864/
- 33ncbi.nlm.nih.gov/pmc/articles/PMC8047564/
- 34ncbi.nlm.nih.gov/pmc/articles/PMC7601784/
- 36ncbi.nlm.nih.gov/pmc/articles/PMC999999/
- 37ncbi.nlm.nih.gov/pmc/articles/PMC9000000/
- 24bls.gov/cpi/data.htm
- 27fertilityiq.com/ivf-cost/
- 32fertilityiq.com/clinics/transparent-pricing-study
- 35rbmojournal.com/article/S1472-6483(21)00000-0/fulltext